Secretory phospholipase A2-IIA in Alzheimer's disease and inflammatory responses in astrocytes by Jensen, Michael D., 1979-
Public Abstract
First Name:Michael
Middle Name:Daniel
Last Name:Jensen
Adviser's First Name:Grace
Adviser's Last Name:Sun
Co-Adviser's First Name:
Co-Adviser's Last Name:
Graduation Term:FS 2009
Department:Biochemistry
Degree:PhD
Title:SECRETORY PHOSPHOLIPASE A2-IIA IN ALZHEIMERS DISEASE AND INFLAMMATORY
RESPONSES IN ASTROCYTES
Alzheimer's disease (AD) is a progressive, fatal neurodegenerative disease and is the most common form
of dementia. AD pathology includes neurofibrillary tangles, amyloid plaques, chronic inflammation, and
oxidative stress. Secretory phospholipase A2-IIA (sPLA2-IIA) is an inflammatory protein known to have a
role in the pathogenesis of multiple inflammatory diseases and is implicated in several neurodegenerative
diseases. In AD, astrocytes become reactive and have increased expression of inflammatory cytokines
such as IL-1beta and TNF-alpha, and undergo increased oxidative stress. NADPH oxidase is one of the
major enzymatic sources of reactive oxygen species in the central nervous system; activation of this
enzyme may contribute to increased oxidative stress in cells of AD brains, including astrocytes. The
expression and localization of sPLA2-IIA in human AD brains has not been studied in detail. In these
studies, we show that sPLA2-IIA mRNA is up-regulated in AD brains (compared to non-demented elderly
brains) and sPLA2-IIA immunoreactivity is increased in AD astrocytes. To further elucidate involvement of
oxidative pathways in induction of sPLA2-IIA mRNA and protein by pro-inflammatory cytokines, we
performed in vitro studies with immortalized astrocytes (DITNC). These studies demonstrated the
involvement of PI-3 kinase and ERK1/2, but not p38 MAPK, in the cytokine-induced sPLA2-IIA expression
in astrocytes. Furthermore, inhibition of sPLA2-IIA mRNA expression by apocynin, a known NADPH
oxidase inhibitor, and botanical antioxidants including resveratrol and epigallocatechin gallate, suggests the
involvement of oxidative pathways, possibly the NADPH oxidase pathway. These results, taken together,
identify sPLA2-IIA as an inflammatory factor for Alzheimer's disease, and support the involvement of
NADPH oxidase in the cytokine induction of sPLA2-IIA in astrocytes and the possibility of using botanical
antioxidants to ameliorate the inflammatory response in these cells.
